Increased cerebrospinal fluid glutamine levels in depressed patients.
about
Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disordersNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsReview of pharmacological treatment in mood disorders and future directions for drug development.Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to dateA brief history of the development of antidepressant drugs: from monoamines to glutamateThe positive effect on ketamine as a priming adjuvant in antidepressant treatment.The 1H NMR profile of healthy dog cerebrospinal fluid.Delineation of molecular pathway activities of the chronic antidepressant treatment response suggests important roles for glutamatergic and ubiquitin-proteasome systemsEpigenetic Activation of ASCT2 in the Hippocampus Contributes to Depression-Like Behavior by Regulating D-Serine in Mice.Involvement of the glutamate/glutamine cycle and glutamate transporter GLT-1 in antidepressant-like effects of Xiao Yao san on chronically stressed miceElevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depressionLow nNOS protein in the locus coeruleus in major depressionMagnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disordersMemantine: a review of possible uses in child and adolescent psychiatryBeyond serotonin: newer antidepressants in the future.Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatmentReduced cerebrospinal fluid ethanolamine concentration in major depressive disorder.Ketamine and the next generation of antidepressants with a rapid onset of actionEnhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathwaysMetabolomic differences in heart failure patients with and without major depressionA hypothetical astrocyte-microglia lactate shuttle derived from a (1)H NMR metabolomics analysis of cerebrospinal fluid from a cohort of South African children with tuberculous meningitis.Age-Related 1H NMR Characterization of Cerebrospinal Fluid in Newborn and Young Healthy PigletsOverview of Glutamatergic Dysregulation in Central Pathologies.Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder.The As and Ds of stress: metabolic, morphological and behavioral consequences.Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.Neurometabolic effects of ACTH on free amino compounds in opsoclonus-myoclonus syndromeTargeting the glutamatergic system to develop novel, improved therapeutics for mood disordersThe Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related DisordersThe role of the tripartite glutamatergic synapse in the pathophysiology and therapeutics of mood disorders.The role of memantine in the treatment of psychiatric disorders other than the dementias: a review of current preclinical and clinical evidence.Glutamate system as target for development of novel antidepressants.Serotonergic modulation of glutamate neurotransmission as a strategy for treating depression and cognitive dysfunctionA complex interaction between glycine/NMDA receptors and serotonergic/noradrenergic antidepressants in the forced swim test in mice.Citrate, a Ubiquitous Key Metabolite with Regulatory Function in the CNS.Uncoupling DAPK1 from NMDA receptor GluN2B subunit exerts rapid antidepressant-like effects.Glutamatergic system abnormalities in posttraumatic stress disorder.Current Status of Ketamine and Related Therapies for Mood and Anxiety Disorders.Mitochondria are critical for BDNF-mediated Synaptic and Vascular plasticity of Hippocampus following Repeated Electroconvulsive Seizures.
P2860
Q24632936-0902F4AE-F9C9-444B-8D4E-7E6B4605CBEAQ24656267-7F1F7E2E-50A8-4C43-892D-9626EBDA13DEQ26853509-823F4A7F-6F3F-411D-BC3E-EC8666E7AF92Q27004490-8746B1D2-B02C-4AD6-B0DD-9738A82362EBQ27028050-093CEE66-6DBC-4583-A5B4-FEE3ED8EF44DQ30408646-C22E7307-BA01-4609-B20D-8ED45B8F723AQ31146776-254D6746-580C-4A14-947A-64B73FB636F7Q33635613-0D550444-4289-49B0-85CB-FD5D56B0FA28Q33650476-B6797682-820F-4F27-A3AB-89BBAB4D9DBCQ33814381-8086FBAC-C188-4C41-946D-C6720E501C80Q34065490-B92F0CCE-F27F-4698-A7C5-A8B9518A6542Q34071706-0DF6D5FD-D7A5-4514-AA64-59974E32F0A9Q34204211-E0BA6C36-286F-4547-BEC5-F06EE712A375Q34344303-53AAE247-A946-43FD-8F07-AC644D83ABB1Q34557706-99C93822-F5AC-4874-8513-6917E5C739EBQ34661625-18D86CAE-BCF6-4373-B422-3FB3861C0CFCQ34965754-7CA82110-ECB0-4784-BA26-7F3419C5E229Q34978041-15DF8EB3-CCB1-4F18-8DC0-8060FCCC9D31Q35236446-A6A30118-728F-431A-883E-0443DF240D3EQ35610645-8E5793DC-8EAF-4F4E-B7C2-17E1A0A2B7F8Q35757760-B46A33A5-E579-4D7A-8DAC-353458554C7EQ35763118-52087621-C5C9-494F-89F5-0A0D6DC59535Q36071030-CF77C717-4DB5-4E9C-B851-C20EA8FA0A78Q36409596-7098E601-82B5-431B-8A02-35018670D52DQ36540042-43AFC15A-62C6-4C49-AE70-ECF7DE4CBC93Q36710935-49A4442C-1F35-449D-8B98-13DD91262C97Q36915565-8B6BF3B1-0981-4A2E-84E1-551A7F0F1277Q37140513-EA7BDA79-063E-4A29-BE69-656259D73607Q37143117-DBE05CE2-C7F0-49F9-A852-A57C99BD89C0Q37172873-6D643DF8-67E3-416A-825D-C0E66E32DC13Q37387700-A0C82071-6F0F-4D84-8856-C564C0D32BC7Q38025454-7F0B849B-4804-4B86-8017-DDF89EDA823BQ38078152-74D120D3-22BF-4E46-BA16-9E221304EBE4Q38125568-B1A80141-DADB-41C0-85CE-C85532CCE9EAQ38771892-6CC52F7B-48CA-4091-853B-7CAE2AAFE291Q39069512-F9F68628-72AE-4AB1-857B-0030EB9BF546Q40229544-B9FB321A-EB21-4F30-9734-1B96646C756FQ41952721-31819468-6A0A-4476-A6C6-BDC027B2A349Q43086364-4E255128-3F27-4C67-9862-31FEEF94E38BQ47307417-E89997D2-3B98-40AF-93BA-1969B6E8A5CF
P2860
Increased cerebrospinal fluid glutamine levels in depressed patients.
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Increased cerebrospinal fluid glutamine levels in depressed patients.
@ast
Increased cerebrospinal fluid glutamine levels in depressed patients.
@en
type
label
Increased cerebrospinal fluid glutamine levels in depressed patients.
@ast
Increased cerebrospinal fluid glutamine levels in depressed patients.
@en
prefLabel
Increased cerebrospinal fluid glutamine levels in depressed patients.
@ast
Increased cerebrospinal fluid glutamine levels in depressed patients.
@en
P2093
P1476
Increased cerebrospinal fluid glutamine levels in depressed patients.
@en
P2093
McClure RJ
Panchalingam K
Pettegrew JW
Rapoport A
P304
P356
10.1016/S0006-3223(99)00284-X
P407
P577
2000-04-01T00:00:00Z